- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
What's New on Dermatology Times: July 18-22
Author(s):
Click to see a preview of what to expect this week.
Some of the content the staff at Dermatology Times® will be publishing this week includes:
Content about new treatment methods for eczema;
Coverage on the influences of TikTok trends in plastic surgery;
New Phase I/II Basal Cell Carcinoma Data;
Exclusive video interviews with KOLs;
Plus more!
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Future Directions for IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis Care
Future Perspectives: Can Innovative Topical Therapies Like Ruxolitinib Reduce Systemic Treatment Dependency in Pediatric AD?
Treatment Escalation and De-escalation Strategies in Pediatric AD: Positioning Ruxolitinib Cream in Clinical Decision-Making
Benefits of Nonsteroidal Topical JAK Inhibitors for Moderate Pediatric Atopic Dermatitis
Identifying and Addressing Critical Gaps in Pediatric Atopic Dermatitis Treatment with Ruxolitinib Cream
Utility of Head-to-Head Studies in Atopic Dermatitis and Future Research Directions
Utility of Head-to-Head Studies in Psoriasis Management
Things to Consider With Treatment Sequencing for Pediatric Atopic Dermatitis
Larry Eichenfield, MD: Icotrokinra Demonstrates Promising Results for Adolescents With Moderate to Severe Plaque Psoriasis
Case 2: Poorly Managed GPP Flares and Effisayil 2 Trial Results
Related Content
